Michael Mayr

Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany.

Part of Fresenius SE & Co. KGaA, Beijing Fresenius Kabi Pharmaceutical Co. Ltd. is a company that manufactures infusion solutions for volume therapy and standard infusion solutions. Beijing Fresenius Kabi Pharmaceutical Co. Ltd. is based in Beijing, China. Beijing Fresenius Kabi Pharmaceutical Co. was acquired by Fresenius Kabi AG on April 05, 2005 for $30.21 million.

Fenwal, Inc. is a global medical technology company focused on improving transfusion medicine through expertise in blood separation, collection, filtration, storage, and transfusion. It offers apheresis collections, manual collections, therapeutics, specialty products, platelet safety, data management, data management, and customer solutions The company was founded in 1949 and is headquartered in Lake Zurich, IL.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Japan KK is a leading Japanese company for infusion therapy, nutrition therapy, and blood transfusion technology products. The company is based in Tokyo, Japan. The company provides drugs and medical equipment to patients with severe chronic diseases, which are indispensable in acute care and used to treat patients at the hospital and home.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi España SA is a company based in Barcelona, Spain that develops and produces drugs and medical devices for critical care therapies with chronic diseases worldwide. The Spanish company offers a wide range of products, including substitution of blood volume, critical disease, diabetes mellitus, liquid management, hepatic insufficiency, digestive problems/absorption, nutritional support, pediatrics, renal insufficiency, enteral nutrition, nasogastric probe food, oral nutritional supplements, anesthetic, generic medicines/antibiotic, analgesic, oncology, and other fluid therapy infion medical irrigation devices. Fresenius Kabi is committed to putting essential medicines and technologies in the hands of people who help patients and find the best responses to the challenges they face.

Founded in 1966, FHC (Holdings) Ltd. is a British company that functions as an investment holding company. Part of Fresenius SE & Co. KGaA, the company is based in Runcorn, UK.

Labesfal-Laboratórios Almiro SA is a pharmaceutical company based in Santiago de Besteiros, Portugal. Part of Fresenius SE & Co. KGaA, the Portuguese company develops, produces, and markets medical drugs and devices for therapy and the care of critical and chronic patients worldwide. The company's product portfolio includes diabetes mellitus, critical disease, fluidotherapy, hepatic insufficiency, renal insufficiency, maldigestion/malabsorption, oncology, pediatrics, replacement nutritional support, medical devices, disposable devices, drainage manipulation technology, infusion technology, nutrition, enteric nutritional supplements, parenteral nutrition, specific amino acids, lipid emulsions, volume replacement, colloids, irrigation solutions, transfusion technology, and more. The company is committed to ethics, responsibility, compliance, diversity, integrity, safety, and social responsibility. The company also prioritizes career development and employee well-being.

Fresenius Kabi Italia Srl specializes in drugs and technologies for infusion, transfusion and clinical nutrition. The firm’s products include autologous, colloids, biosimilars, enteral nutrition, and infusion therapy. The company is headquartered in Isola della Scala, Italy.

Part of Fresenius SE & Co. KGaA, Fresenius HemoCare Beteiligungs GmbH is a German company that provides investment services. The company is based in Bad Homburg vd Höhe, Germany. The CEOs of the company are Gerrit Steen, Mats Christer Henriksson.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients.

Part of Else Kröner-Fresenius-Stiftung, Fresenius Management SE is a German company that provides investment management services. The company is based in Bad Homburg vor der Hoehe, Germany. The company was founded in 2010. Michael Sen has been the CEO of the company since 2021.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Pharmaceuticals Holding, Inc. is a pharmaceutical company based in Wilmington, DE. The company develops pharmaceutical products.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi (Singapore) Pte Ltd. is a Singaporean healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company is based in Singapore, Singapore. Fresenius Kabi's corporate philosophy is "caring for life," and they offer information about their business fields and career opportunities on their website.

Part of Else Kröner-Fresenius-Stiftung, Fresenius Kabi USA, Inc. develops, manufactures and delivers pharmaceuticals and medical devices. The company is based in Wilmington, DE.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi LLC is a healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company is based in Dover, DE.